Host Matt Fisher talks to Dr. Joel Diamond, Chief Medical Officer at Aranscia, about defining genetics, genomics, and molecular testing; switching treatment from body area to specific genetic makeup; the connection to precision medicine and recognizing individual variations; defining pharmacogenetic … Read More

Good news for CA providers and residents! Starting July 1, 2024, Pharmacogenomic (PGx) biomarker testing will be a covered benefit for all Californians*, regardless of insurance provider. PGx testing is already a covered benefit for Medicare patients. Read the press … Read More